BPA Call HT001414A0004-0002

Award Date 9/17/14
Potential Completion Date 9/30/14
Potential Value $150K
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Defense Health Agency
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Defense's Bureau of Medicine and Surgery to TDS Med, Inc., a self-certified small disadvantaged business, to provide various pharmaceutical products. The $250,000 award has an ultimate completion date of September 30, 2015. TDS Med, Inc. has provided pharmaceutical products and medical supplies in support of COVID-19 response efforts and to address shortages for the Defense Health Agency and...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business, to provide pharmaceutical supplies and drugs for the Walter Reed National Military Medical Center (WRNMMC). The $300,000 contract has an ultimate completion date of September 30, 2015 and was awarded on June 30, 2015. TDS Med, Inc. is an active federal contractor that has previously supported COVID-19 response...
The Defense Health Agency awarded a Blanket Purchase Agreement Call contract to TDS Med, Inc. valued at one hundred thousand dollars with a period of performance through December 2nd, 2020. The contract supports the agency's shortage pharmaceutical supplies program and involves the delivery of blood products, relevant pharmaceuticals including orals, injectables, and medical inhalations to address shortages. The firm fixed price contract was awarded on December 3rd, 2019 without a set-aside...
This $150,000 firm-fixed-price contract was awarded to TDS Med, Inc., a self-certified small disadvantaged business, by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense. The contract is for the provision of pharmaceutical shortage items, including blood products, injectables, and medical inhalations, to support BUMED's mission. This contract is a call against a larger $2 million Blanket Purchase Agreement (BPA) that TDS Med, Inc. holds with the Defense...
The Defense Health Agency awarded a firm fixed price blanket purchase agreement (BPA) call to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, to provide prescription pharmaceuticals such as vinblastine, carimune, and oncological medications. The $250,000 contract has no set-aside designation and supports the urgent needs of military treatment facilities, including Walter Reed National Military Medical Center, by delivering specialized, customized...
This is a $150,000 firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Bureau of Medicine and Surgery, a Defense agency, to Broughton Pharmaceuticals, LLC, a for-profit limited liability company. The contract is for the provision of pharmaceutical shortage supplies, including products such as RYDAPT, Novolog insulin, Carimune, and oncological drugs, as well as personal protective equipment (PPE) like N95 masks and disinfectant wipes. This BPA call is part of a larger...
The U.S. government agency Medical Supply Chain (also known as the Defense Logistics Agency (DLA) Troop Support Medical) awarded a delivery order contract worth $73,371.80 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which enables the DLA to efficiently procure a wide range of pharmaceutical products and medical supplies for the U.S....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a potential value of $294,150.00 and provides a range of pharmaceutical products and medical supplies to support military treatment facilities worldwide. This order was issued against an existing indefinite delivery contract with DLA Troop Support Medical, which has a potential value up to $5 million through...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $144,096.27 contract is for the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract supports...
This federal contract award, valued at $38,321.60, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 25, 2025. The award was not set aside for any specific business category. The contract covers the provision of a broad range of pharmaceutical products and medical...

The U.S. Defense Health Agency awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract to TDS Med, Inc., a small disadvantaged business, to provide pharmaceutical shortage supplies. The contract has a ceiling value of $150,000.00 and a period of performance ending on September 30, 2014. This contract is issued under a larger $2 million BPA awarded to TDS Med, Inc. in September 2019 to provide pharmaceutical products and supplies to the Defense Health Agency. TDS Med, Inc. has previously supported COVID-19 response efforts and provided pharmaceutical products to address shortages for other federal agencies.

Generated 7/27/24, 9:01 AM